SVG Sprites

Press

Press Releases 08.02.2021

On Medicare Anniversary, Members of Congress, Seniors, Veterans, Labor, Tribal Leaders Call on Senate to Allow Medicare to Negotiate Drug Prices

On the anniversary of Medicare, Lower Drug Prices Now is joining Members of Congress, seniors, veterans, labor leaders, tribal leaders, faith leaders, patients and local organizers to hold 18 events across the country calling on the Senate to allow Medicare to negotiate drug prices in the budget reconciliation bill currently being negotiated.

Press Releases 07.29.2021

Medicare rebate rule can’t be the end of action to lower drug prices

Delaying the Medicare rebate rule is a step in the right direction for patients struggling to afford their prescription medication. But preventing cost-shifting is not a substitute for real reforms that rein in drug corporations’ monopoly power to raise prices anytime they want. 

Press Releases 07.21.2021

The opioid settlement makes a mockery of justice.

This settlement makes a mockery of justice. While four of the most profitable drug corporations in the world agree to share a fraction of their profits with victims of opioids, not one of the executives responsible for this epidemic is being held accountable.

Press Releases 07.13.2021

Biden’s drug price actions helpful, but Congress must do more to lower drug prices for all.

These actions by President Biden — importation and ending pay-for-delay on generics — are helpful steps to increase competition and access for patients on some drugs. But these steps alone won’t fundamentally solve the problem of price gouging by pharmaceutical corporations that have monopoly power to set and increase prices whenever they want.

Press Releases 07.06.2021

New drug price hikes highlight urgent need for drug price reform

For the pharmaceutical industry, Independence Day is secondary to their favorite reason to celebrate in July: price hikes always come first.

Press Releases 06.22.2021

Senate Finance drug reform principles are an important step. Now we need action.

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on the Senate Finance Committee’s Principles for Drug Pricing Reform:

“The principles for drug pricing reform released by the Senate Finance Committee are a big step in the right direction and demonstrate that Chairman Wyden plans to prioritize patients,

Press Releases 06.11.2021

Biogen’s price gouging is why Congress must pass HR3, now.

The hefty price tag for Biogen’s new Alzheimer’s drug proves that when drug corporations have monopoly power to set prices, they will set them ridiculously high. Biogen is selling false hopes, rather than clinical results, to desperate families — but still stands to make a profit. Already since the announcement of the FDA’s approval, Biogen’s share price has skyrocketed.  

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles